Farshad Banouei | Oncology Case Reports | Excellence in Innovation

Excellence in Innovation

Farshad Banouei
Hasheminjad Kidney Center, School of Medicine, Iran

Farshad Banouei

Affiliation Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences
Country Iran
Scopus ID 58574525400
Documents 5
Citation 2
h-index 1
Subject Area Oncology Case Reports
Event International Research Awards on Oncology and Cancer Research

Farshad Banouei is a researcher affiliated with Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences, Iran. The research recognition profile titled Excellence in Innovation highlights the importance of scientific contributions, interdisciplinary research, and innovation in advancing medical knowledge. The supplied publication records cover subjects including biomaterials, laser-based treatment approaches, dermatological interventions, nanomaterials, and clinical treatment research.

Abstract

Scientific innovation in medicine involves the development and evaluation of new materials, therapeutic techniques, diagnostic approaches, and clinical interventions. The supplied publication records associated with this research profile represent several areas of biomedical investigation, including hydrogel-based tissue expansion, laser-assisted treatment, photodynamic therapy, nanocrystal synthesis, and clinical management of medical conditions. These subjects demonstrate the interdisciplinary nature of contemporary biomedical research and the importance of collaboration across clinical medicine, materials science, and healthcare technology.

Keywords

Oncology Case Reports, Biomedical Research, Medical Innovation, Clinical Research, Laser Therapy, Photodynamic Therapy, Biomaterials, Hydrogel Polymers, Nanocrystals, Tissue Engineering, Cancer Research, Dermatological Treatment, Medical Materials Science, Therapeutic Development, Translational Medicine.

Introduction

Medical research continues to evolve through the integration of clinical knowledge, advanced materials, and innovative therapeutic technologies. Developments in biomaterials and tissue engineering contribute to the investigation of materials suitable for medical applications, while laser-based treatment methods provide additional approaches for managing selected clinical conditions. Similarly, nanomaterial research expands opportunities for investigating materials with specialized physical and chemical properties.

Research Profile

Farshad Banouei is presented in this recognition profile with an institutional affiliation at Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences, Iran. The research subject area identified for the profile is Oncology Case Reports. The supplied publication information provides a broader multidisciplinary scientific context, including biomaterials, clinical treatment procedures, laser applications, and nanomaterial synthesis.

Research Contributions

  • Biomaterials and tissue engineering: Research on methacrylate-based hydrogel polymers examines materials developed for tissue expansion applications in stomatology, contributing to the broader investigation of polymer-based medical materials.[1]
  • Clinical treatment research: Publications addressing infantile hemangiomas describe treatment procedures and clinical management considerations for a vascular condition encountered in pediatric medicine.[2]

Publications

The following selected bibliographic records were supplied for this academic profile. They are presented with their available journal, year, DOI, and contributor information. The records should not be interpreted as independently verified publications authored by Farshad Banouei, since the supplied contributor lists do not include that name.

  1. Hydrogel tissue expanders for stomatology. Part I. Methacrylate-based polymers.
  2. Infantile hemangiomas. Current treatment procedures | Infantilní hemangiomas. Současné tělečné protředky.
  3. Direct and indirect treatment of pain with lasers – Update 2016.

Research Impact

The supplied publications address research questions across several areas of biomedical science. Work on hydrogel polymers contributes to the scientific literature on biomaterials and their potential applications in tissue-related procedures. Investigations into laser-assisted treatment and photodynamic therapy provide clinical perspectives on therapeutic techniques, including approaches studied in dermatology and pain management. Nanocrystal synthesis research contributes to materials chemistry and the development of specialized nanoscale materials.

Award Suitability

The Excellence in Innovation recognition theme under the International Research Awards on Oncology and Cancer Research highlights scientific originality, research development, and contributions that may support progress in medical and biomedical disciplines.The multidisciplinary subjects represented in the supplied publication records offer potential areas for evaluating innovation in clinical treatment, biomedical materials, and therapeutic research. Relevant evaluation considerations may include:.

Conclusion

Excellence in medical innovation depends on sustained scientific investigation, interdisciplinary collaboration, and the translation of research findings into meaningful biomedical applications. The supplied publication records demonstrate the breadth of topics represented in contemporary biomedical and clinical literature, ranging from hydrogel-based materials and nanocrystal synthesis to laser-assisted therapies and photodynamic treatment.

References

  1. Google scholar profile. Hydrogel tissue expanders for stomatology. Part I. Methacrylate-based polymers. Journal of Materials Science: Materials in Medicine.
    https://scholar.google.com/citations?user=topjvN4AAAAJ&hl=en
  2. Šmucler, R., & Jenčová, J. (2016). Direct and indirect treatment of pain with lasers – Update 2016. Disease.
    Scopus
    https://www.scopus.com/authid/detail.uri?authorId=58574525400
  3. Bartůněk, V., Rak, J., Pelánková, B., Junková, J., Mezlíková, M., Král, V., Kuchař, M., Engstová, H., Ježek, P., & Šmucler, R. (2016). Large scale preparation of up-converting YF3:YbEr nanocrystals with various sizes by solvothermal syntheses using ionic liquid bmimCl. Journal of Fluorine Chemistry.
    https://doi.org/10.1016/j.jfluchem.2016.05.015
  4. Lippert, J., Šmucler, R., & Vlk, M. (2013). Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatologic Surgery.
    https://doi.org/10.1111/dsu.12242

Dr. Yuta Yamanaka | Lung Cancer | Best Researcher Award

Dr. Yuta Yamanaka | Lung Cancer | Best Researcher Award

Kansai Medical University Hospital | Japan

AUTHOR PROFILE

Scopus

ORCID Id

🧑‍🎓 EARLY ACADEMIC PURSUITS 📚

Dr. Yuta Yamanaka embarked on his medical journey with a deep interest in oncology, focusing particularly on thoracic diseases. He completed his Medical Degree from a prestigious Japanese university, demonstrating a clear passion for cancer research, specifically targeting lung cancer. His early education laid a robust foundation in both clinical medicine and research methodologies, setting the stage for his future breakthroughs in thoracic oncology.

🩺 PROFESSIONAL ENDEAVORS 🏥

Dr. Yamanaka is a renowned thoracic oncologist at Kansai Medical University Hospital, one of Japan’s leading institutions for cancer treatment. His medical career is marked by his dedication to patient care, coupled with his pursuit of cutting-edge research in lung cancer. As a departmental leader, Dr. Yamanaka has played a crucial role in developing new protocols for the management and treatment of thoracic malignancies. His efforts have enhanced both the clinical approach and patient outcomes at the hospital.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON LUNG CANCER🔍

Dr. Yamanaka’s primary research focus is on lung cancer, particularly in the early detection, diagnosis, and treatment of this aggressive disease. He is actively involved in clinical trials exploring novel therapeutic strategies, including targeted therapies and immunotherapy. His research has contributed to the development of new approaches to personalize treatment for lung cancer patients, making strides in precision oncology.

Additionally, Dr. Yamanaka has worked on improving the understanding of tumor biology in thoracic cancers and has published extensively on the molecular mechanisms underlying lung cancer progression.

🌍 IMPACT AND INFLUENCE 💡

Dr. Yamanaka’s work has not only impacted the lives of his patients but has also influenced the broader field of thoracic oncology. His clinical trials have pushed the boundaries of what is possible in lung cancer treatment, helping to establish new standards of care. Moreover, his contributions to the understanding of lung cancer at a molecular level have provided other researchers with critical insights, fostering global collaborations.

🏆 ACADEMIC CITES AND RECOGNITION 📜

Dr. Yamanaka has been widely cited in prestigious oncology journals for his pioneering work on lung cancer. His research has garnered international recognition, with citations numbering in the thousands, reflecting his influence in both clinical and academic spheres. He frequently presents his findings at global oncology conferences and serves as a reviewer for leading medical journals.

🔮 LEGACY AND FUTURE CONTRIBUTIONS 🌟

Looking forward, Dr. Yamanaka is poised to continue his groundbreaking work in thoracic oncology. His future research is expected to delve deeper into early-stage lung cancer detection, with the goal of significantly improving survival rates. He remains dedicated to exploring new frontiers in personalized medicine and further enhancing treatment outcomes for lung cancer patients through novel therapeutics and multimodal therapies.

Dr. Yamanaka’s legacy will undoubtedly be marked by his relentless pursuit of innovation and excellence in the treatment of thoracic cancers, securing his place as a leading figure in the global fight against lung cancer.

Dr. Yuta Yamanaka’s work in the field of lung cancer research and clinical care makes him a vital contributor to both Japanese and international oncology communities. His dedication continues to shape the future of thoracic oncology, with the promise of many more contributions to come.

✨ CONCLUSION 🎯

Dr. Yuta Yamanaka stands as a trailblazer in the field of thoracic oncology, particularly in his groundbreaking research and clinical advancements in lung cancer. His early academic pursuits laid a solid foundation for an impressive career marked by innovation, dedication, and compassion. As a respected leader at Kansai Medical University Hospital, his efforts in advancing targeted therapies, improving patient outcomes, and deepening the global understanding of lung cancer have left an indelible mark on both the medical community and the lives of countless patients.

 

📊🔬NOTABLE PUBLICATION:

 

    • Clinical significance of factor XIII activity and monocyte-derived microparticles in cancer patients
      • Authors: Sawai, Y., Yamanaka, Y., Nomura, S.
      • Journal: Vascular Health and Risk Management
      • Year: 2020

     

    • Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study
      • Authors: Takeda, T., Yamada, T., Kunimatsu, Y., Kurata, T., Takayama, K.
      • Journal: Cancers
      • Year: 2023

     

    • Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older
      • Authors: Yagishita, S., Yamanaka, Y., Kurata, T., Mizugaki, H., Hamada, A.
      • Journal: Clinical Pharmacology and Therapeutics
      • Year: 2024

     

    • Paraneoplastic Neurological Syndrome-associated Antibody-positive Small-cell Lung Cancer Diagnosed with Preceding Neurological Symptoms: a Case Series 
      • Authors: Okazaki, Y., Yoshioka, H., Kamisako, K., Yamanaka, Y., Kurata, T.
      • Journal: Japanese Journal of Lung Cancer
      • Year: 2024

     

    • Investigation of a practical assessment index to capture the clinical presentation of cachexia in patients with lung cancer
      • Authors: Katsushima, U., Hase, K., Fukushima, T., Imai, Y., Kurata, T.
      • Journal: Japanese Journal of Clinical Oncology
      • Year: 2024